Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

PDMP analogues studied for malaria inhibition

Jan. 21, 1998

Antiviral agents that inhibit virus-host cell fusion pursued by Lilly

Jan. 21, 1998

Novel antifungal peptides isolated by Hoechst Marion Roussel

Jan. 21, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Lilly discloses novel compounds for influenza

Jan. 19, 1998

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Preclinical evaluation of leishmaniasis Rx reported

Jan. 19, 1998

Artelinic acid: an attractive candidate for development as an antimalarial agent

Jan. 19, 1998

New antimalarial agent submitted to extensive clinical testing

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026